Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.
Why AlphaFlo® Has Become a Meaningful Part of My Clinical Approach
By Bree Valensin, DVM In veterinary medicine, no two cases are the same. Every patient, every family, and every clinical situation comes with its own set of variables and that reality shapes how I think about the options I offer in practice. For me, AlphaFlo® fits...